MedTrace Logo

Steroids for Pediatric Apnea Research in Kids

NCT02180672 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 211

Last updated 2021-11-10

Study results available
· View outcomes & findings →

Summary

This double-blind, randomized controlled trial will evaluate the use of nasal corticosteroids for the treatment of the childhood obstructive sleep apnea syndrome (OSAS). Efficacy, duration of action and side-effects will be determined.

Conditions

  • Obstructive Sleep Apnea Syndrome

Interventions

DRUG

Nasal Fluticasone

One spray per nostril, per day.

DRUG

Placebo

One spray per nostril, per day.

Sponsors & Collaborators

Principal Investigators

  • Carole L Marcus, MBBCh · Children's Hospital of Philadelphia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
5 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2019-12-30
Completion
2021-10-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02180672 on ClinicalTrials.gov